Full article: Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy
![Full article: Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy](https://www.tandfonline.com/cms/asset/549b7ddf-b54c-4142-889c-8a961be4c8e1/khvi_a_2052657_f0001_b.gif)
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41390-023-02478-5/MediaObjects/41390_2023_2478_Fig1_HTML.png)
Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40121-023-00864-4/MediaObjects/40121_2023_864_Fig6_HTML.png)
Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older
![](https://s3.amazonaws.com/HMP/c360/imported/Screen%20Shot%202017-01-09%20at%2011.34.29%20AM.png)
Meningococcal Immunization Update: A New Conjugate Vaccine
![](https://www.mdpi.com/microorganisms/microorganisms-08-01521/article_deploy/html/images/microorganisms-08-01521-g001.png)
Microorganisms, Free Full-Text
![](https://www.mdpi.com/microorganisms/microorganisms-08-01521/article_deploy/html/images/microorganisms-08-01521-g003.png)
Microorganisms, Free Full-Text
![](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210420133028153-0386:S0950268821000698:S0950268821000698_fig2.png?pub-status=live)
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study, Epidemiology & Infection
![](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210223191333153-0311:S0950268821000261:S0950268821000261_tab2.png?pub-status=live)
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine
![](https://www.tandfonline.com/cms/asset/549b7ddf-b54c-4142-889c-8a961be4c8e1/khvi_a_2052657_f0001_b.gif)
Full article: Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine ( MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy
![](https://www.futuremedicine.com/cms/10.2217/fmb-2018-0343/asset/images/medium/figure5.gif)
Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence
![](https://www.futuremedicine.com/cms/10.2217/fmb-2018-0343/asset/images/medium/figure2.gif)
Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence
![](https://www.researchgate.net/publication/230578433/figure/tbl1/AS:393580309958705@1470848266909/Conjugated-meningococcal-vaccines.png)
Conjugated meningococcal vaccines.
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40121-023-00864-4/MediaObjects/40121_2023_864_Fig8_HTML.png)
Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older